Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Acadia Healthcare Company, Inc.'s quarterly P/E stands at 129.4x, up 53.6% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has compressed 58.3% YoY to 8.5x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.05 | 129.37 | — | 15.47 | 17.19 | 84.22 | 28.32 | 21.42 | 19.86 | 23.86 | 30.86 | — | 25.20 |
| — | +53.6% | — | -27.8% | -13.5% | +253.0% | -8.2% | — | -21.2% | -4.9% | +0.5% | — | +31.2% | |
| P/S Ratio | 0.69 | 0.64 | 0.39 | 0.66 | 0.59 | 0.91 | 1.18 | 1.79 | 1.95 | 2.37 | 2.40 | 2.14 | 2.49 |
| — | -29.2% | -66.8% | -63.3% | -69.8% | -61.8% | -51.0% | -16.1% | -21.7% | +1.2% | -14.1% | -20.6% | +5.0% | |
| P/B Ratio | 1.05 | 0.98 | 0.60 | 0.68 | 0.64 | 0.88 | 1.14 | 1.86 | 2.03 | 2.45 | 2.47 | 2.28 | 2.42 |
| — | +11.5% | -47.5% | -63.3% | -68.6% | -64.1% | -53.8% | -18.5% | -16.2% | +8.7% | -5.1% | -9.9% | +7.2% | |
| P/FCF | — | 8.63 | — | — | — | — | — | — | 91.93 | — | — | 163.40 | 24.99 |
| — | — | — | — | — | — | — | — | +267.9% | — | — | — | +8.7% | |
| EV / EBITDA | 8.33 | 8.51 | 10.18 | 6.81 | 5.63 | 20.42 | 9.89 | 10.51 | 11.35 | 13.92 | 13.33 | 11.66 | 7.38 |
| — | -58.3% | +3.0% | -35.2% | -50.4% | +46.7% | -25.8% | -9.8% | +53.7% | +82.8% | +55.2% | +44.1% | +2.8% | |
| EV / EBIT | 12.40 | 13.83 | — | 14.85 | 12.64 | 29.47 | 20.77 | 15.13 | 14.96 | 17.84 | 17.10 | 14.55 | 16.12 |
| — | -53.1% | — | -1.8% | -15.5% | +65.2% | +21.4% | +3.9% | -7.2% | -1.3% | -18.1% | -20.1% | +3.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Acadia Healthcare Company, Inc.'s operating margin was 10.1% in Q1 2026, up 4.3 pp QoQ and up 8.4 pp YoY. The trailing four-quarter average of 11.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 49.3% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.6% | 16.5% | 11.7% | 96.4% | 96.7% | 32.6% | 96.3% | 96.4% | 24.0% | 22.7% | 23.0% | 24.0% | 43.6% |
| — | -49.3% | -87.9% | +0.1% | +303.6% | +43.4% | +319.4% | +302.0% | -45.0% | -44.2% | -45.3% | -44.6% | -1.2% | |
| Operating Margin | 11.7% | 10.1% | 5.8% | 14.0% | 16.4% | 1.7% | 13.4% | 18.0% | 17.9% | 16.8% | 16.8% | 17.9% | 36.0% |
| — | +478.7% | -56.6% | -22.2% | -8.7% | -89.6% | -20.6% | +0.8% | -50.2% | -49.6% | -50.9% | -49.6% | -0.5% | |
| Net Margin | -33.3% | 0.5% | -143.3% | 4.3% | 3.5% | 1.1% | 4.2% | 8.4% | 9.9% | 9.9% | 7.8% | -29.0% | 9.9% |
| — | -54.4% | -3502.8% | -49.0% | -64.8% | -89.1% | -45.8% | +128.8% | -0.3% | +6.1% | -14.1% | -372.1% | -19.5% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -41.4% | 0.2% | -43.4% | 1.1% | 0.9% | 0.3% | 1.0% | 2.2% | 2.6% | 2.6% | 2.0% | -7.5% | 2.4% |
| — | -27.6% | -4312.8% | -49.3% | -63.8% | -89.9% | -49.2% | +129.3% | +6.8% | +15.1% | -5.0% | -393.0% | -18.2% | |
| ROA | -19.2% | 0.1% | -19.7% | 0.6% | 0.5% | 0.1% | 0.6% | 1.2% | 1.4% | 1.4% | 1.1% | -4.1% | 1.4% |
| — | -46.5% | -3676.4% | -51.7% | -65.5% | -90.1% | -48.9% | +128.4% | -1.1% | +6.7% | -12.4% | -386.6% | -13.9% | |
| ROIC | 5.9% | 1.3% | 0.7% | 1.6% | 2.0% | 0.2% | 1.5% | 2.2% | 2.2% | 2.1% | 2.2% | 2.3% | 4.5% |
| — | +607.0% | -53.9% | -26.4% | -9.8% | -91.0% | -31.4% | -5.5% | -51.2% | -47.6% | -45.4% | -44.7% | +4.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Acadia Healthcare Company, Inc.'s Debt/EBITDA ratio is 19.6x, down from 28.4x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 26.7% YoY to 1.71x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.23 | 1.24 | 0.74 | 0.74 | 0.73 | 0.65 | 0.64 | 0.64 | 0.67 | 0.52 | 0.54 | 0.51 |
| — | +67.9% | +89.8% | +15.5% | +14.9% | +9.8% | +24.9% | +19.0% | +26.4% | +25.2% | -0.8% | -1.6% | -10.0% | |
| Debt / EBITDA | 4.60 | 19.59 | 28.43 | 14.53 | 12.47 | 37.82 | 14.58 | 10.88 | 11.04 | 12.02 | 9.42 | 8.99 | 5.20 |
| — | -48.2% | +94.9% | +33.6% | +13.0% | +214.5% | +54.8% | +20.9% | +112.3% | +104.7% | +61.2% | +55.1% | -11.2% | |
| Current Ratio | 1.55 | 1.71 | 1.55 | 1.44 | 1.32 | 1.35 | 1.00 | 1.07 | 1.18 | 1.27 | 0.67 | 0.81 | 1.34 |
| — | +26.7% | +55.1% | +35.0% | +11.9% | +6.6% | +48.5% | +31.5% | -11.8% | -11.0% | -48.4% | -37.5% | +14.1% | |
| Quick Ratio | 1.54 | 1.70 | 1.54 | 1.43 | 1.31 | 1.34 | 0.99 | 1.06 | 1.17 | 1.25 | 0.67 | 0.81 | 1.33 |
| — | +27.0% | +55.6% | +35.0% | +11.9% | +6.6% | +48.4% | +31.4% | -11.8% | -10.9% | -48.3% | -37.4% | +14.1% | |
| Interest Coverage | -6.68 | 2.19 | -29.83 | 2.09 | 2.42 | 1.46 | 2.26 | 4.29 | 4.65 | 4.74 | 6.11 | 6.48 | 6.46 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ACHC stock.
Acadia Healthcare Company, Inc.'s current P/E is -2.0x. The average P/E over the last 3 quarters is 54.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Acadia Healthcare Company, Inc.'s current operating margin is 11.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Acadia Healthcare Company, Inc.'s business trajectory between earnings reports.